These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22860059)

  • 21. Computational identification of conserved microRNAs and their putative targets in the Hypericum perforatum L. flower transcriptome.
    Galla G; Volpato M; Sharbel TF; Barcaccia G
    Plant Reprod; 2013 Sep; 26(3):209-29. PubMed ID: 23846415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?
    Kholghi G; Arjmandi-Rad S; Zarrindast MR; Vaseghi S
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jun; 395(6):629-642. PubMed ID: 35294606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the hyp-1 gene in early stages of development of Hypericum perforatum L.
    Kosuth J; Katkovcinová Z; Olexová P; Cellárová E
    Plant Cell Rep; 2007 Feb; 26(2):211-7. PubMed ID: 16988829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA Barcoding of St. John's wort (Hypericum spp.) Growing Wild in North-Eastern Greece.
    Pyrka I; Stefanaki A; Vlachonasios KE
    Planta Med; 2021 Jun; 87(7):528-537. PubMed ID: 33618378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reference genes selection and normalization of oxidative stress responsive genes upon different temperature stress conditions in Hypericum perforatum L.
    Velada I; Ragonezi C; Arnholdt-Schmitt B; Cardoso H
    PLoS One; 2014; 9(12):e115206. PubMed ID: 25503716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX; Venkatanarayanan N; Ho CY
    J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Phillipson JD
    J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J; Klejdus B; Kubán V
    Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypericins: biotechnological production from cell and organ cultures.
    Murthy HN; Kim YS; Park SY; Paek KY
    Appl Microbiol Biotechnol; 2014 Nov; 98(22):9187-98. PubMed ID: 25301586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of UV-B on secondary metabolites of St. John's Wort (Hypericum perforatum L.) grown in controlled environments.
    Brechner ML; Albright LD; Weston LA
    Photochem Photobiol; 2011; 87(3):680-4. PubMed ID: 21275996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Octaketide-producing type III polyketide synthase from Hypericum perforatum is expressed in dark glands accumulating hypericins.
    Karppinen K; Hokkanen J; Mattila S; Neubauer P; Hohtola A
    FEBS J; 2008 Sep; 275(17):4329-42. PubMed ID: 18647343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic diversity in Hypericum and AFLP Markers for species-specific identification of H. perforatum L.
    Percifield RJ; Hawkins JS; McCoy JA; Widrlechner MP; Wendel JF
    Planta Med; 2007 Dec; 73(15):1614-21. PubMed ID: 18072074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convergent gene clusters underpin hyperforin biosynthesis in St John's wort.
    Wu S; Malaco Morotti AL; Wang S; Wang Y; Xu X; Chen J; Wang G; Tatsis EC
    New Phytol; 2022 Jul; 235(2):646-661. PubMed ID: 35377483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. De novo transcriptome sequencing of Rhododendron molle and identification of genes involved in the biosynthesis of secondary metabolites.
    Zhou GL; Zhu P
    BMC Plant Biol; 2020 Sep; 20(1):414. PubMed ID: 32887550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
    Hostanska K; Reichling J; Bommer S; Weber M; Saller R
    Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-genome sequence data of Hypericum perforatum and functional characterization of melatonin biosynthesis by N-acetylserotonin O-methyltransferase.
    Zhou W; Wang Y; Li B; Petijová L; Hu S; Zhang Q; Niu J; Wang D; Wang S; Dong Y; Čellárová E; Wang Z
    J Pineal Res; 2021 Mar; 70(2):e12709. PubMed ID: 33315239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperforin production in Hypericum perforatum root cultures.
    Gaid M; Haas P; Beuerle T; Scholl S; Beerhues L
    J Biotechnol; 2016 Mar; 222():47-55. PubMed ID: 26876610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of anthraquinones and phloroglucinols biosynthesis in Hypericum spp. by cryogenic treatment.
    Bruňáková K; Čellárová E
    J Biotechnol; 2017 Jun; 251():59-67. PubMed ID: 28414068
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.